About 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one
9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one (PubChem CID 72863989) has the molecular formula C17H27N3O2
and a molecular weight of 305.42 g/mol. Its IUPAC name is 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one.
Analyze 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one?
The IUPAC name of 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one (CID 72863989) is 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one.
What is the SMILES notation for 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one?
The canonical SMILES for 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one is CCCn1nc(C)c(CN2CC3(CCOC3)CCC2=O)c1C.
What is the InChIKey of 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one?
The InChIKey is GNPLWPLUDJBGFN-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H27N3O2/c1-4-8-20-14(3)15(13(2)18-20)10-19-11-17(6-5-16(19)21)7-9-22-12-17/h4-12H2,1-3H3.
What are the key properties of 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one?
9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one has a molecular weight of 305.42 g/mol, XLogP of 2.44, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[(3,5-dimethyl-1-propylpyrazol-4-yl)methyl]-2-oxa-9-azaspiro[4.5]decan-8-one is sourced from PubChem (CID 72863989), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).